3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
13
Head and Neck Neoplasms
8
Breast Neoplasms
8
Nasopharyngeal Carcinoma
6
Uterine Cervical Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
4
Oropharyngeal Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Glioma
3
Carcinoma, Squamous Cell
3
Sarcoma, Ewing
2
Sarcoma
2
Rectal Neoplasms
2
Nasopharyngeal Neoplasms
2
Mesothelioma, Malignant
2
Meningeal Carcinomatosis
2
Glioblastoma
2
Wilms Tumor
1
Virus Diseases
1
Tumor Virus Infections
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Stage IA Uterine Sarcoma
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Interventions
Risk Factors
1
Radiotherapy, Intensity-Modulated
1
Nimorazole
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms, Squamous Cell
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled